Megan Durkin
Primary Care · Southampton, PANPI 1093494643
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 219 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 219 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$896
- Novo Nordisk$433
- Amgen$421
- Axsome Therapeutics, Inc.$329
- AstraZeneca$329
- Pfizer$223
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,878100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 75 | $896 |
| Novo Nordisk | 27 | $433 |
| Amgen | 19 | $421 |
| Axsome Therapeutics, Inc. | 11 | $329 |
| AstraZeneca | 17 | $329 |
| Pfizer | 13 | $223 |
| Otsuka America Pharmaceutical, Inc. | 7 | $207 |
| Exact Sciences | 10 | $194 |
| Lilly USA, LLC | 8 | $168 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $142 |
| Astellas Pharma US Inc | 3 | $95 |
| GSK | 5 | $92 |
| Almatica Pharma LLC | 4 | $78 |
| Bausch Health US, LLC | 3 | $61 |
| Ardelyx, Inc. | 3 | $56 |
| Idorsia Pharmaceuticals US Inc | 3 | $53 |
| Kowa Pharmaceuticals America, Inc. | 3 | $43 |
| Johnson & Johnson | 1 | $38 |
| Acella Pharmaceuticals, LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,878 in reported general payments places this provider in the 90th percentile of 300 primary care providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $24,642 |
| Metoprolol Succinate | 27 | $504 |
| Atorvastatin Calcium | 27 | $406 |
| Rosuvastatin Calcium | 12 | $316 |
| Amlodipine Besylate | 11 | $150 |
| Azithromycin | 32 | $118 |
| Prednisone | 20 | $41 |
| Meloxicam | 16 | $34 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $223 | $24,64224 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 300 primary care providers in Pennsylvania.
Other primary care in Southampton
- Kersten ReiderMount Penn$121K
- Teresa GiamboyPhiladelphia$21K
- Nicole IlgenfritzBethel Park$18K
- Galyna VorokhibPhiladelphia$12K
- Melissa BeansWarrington$12K
- Mollie McGuireJohnstown$11K
- Andrea MauriceNew Cumberland$11K
- Kendell SoglieroSmithfield$9K
- Minjung RegerDoylestown$9K
- Mackenzie HouserMedia$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.